Brief: Cleveland Biolabs quarterly loss per share $0.17
15/08/2016 13:32
Aug 15 (Reuters) - Cleveland Biolabs Inc CBLI.O
* Quarterly loss per share $0.17
Source text for Eikon: ID:nMKWjVnJha
Further company coverage: CBLI.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc